Authors: Guthridge, JM Rakstang, JK Young, KA Hinshelwood, J Aslam, M Robertson, A Gipson, MG Sarrias, MR Moore, WT Meagher, M Karp, D Lambris, JD Perkins, SJ Holers, VM

Citation: Jm. Guthridge et al., Structural studies in solution of the recombinant N-terminal pair of shortconsensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg, BIOCHEM, 40(20), 2001, pp. 5931-5941

Authors: Fossella, FV DeVore, R Kerr, RN Crawford, J Natale, RR Dunphy, F Kalman, L Miller, V Lee, JS Moore, M Gandara, D Karp, D Vokes, E Kris, M Kim, Y Gamza, F Hammershaimb, L

Citation: Fv. Fossella et al., Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated withplatinum-containing chemotherapy regimens, J CL ONCOL, 18(12), 2000, pp. 2354-2362

Authors: Gandara, DR Vokes, E Green, M Bonomi, P Devore, R Comis, R Carbone, D Karp, D Belani, C

Citation: Dr. Gandara et al., Activity of docetaxel in platinum-treated non-small-cell lung cancer: Results of a phase II multicenter trial, J CL ONCOL, 18(1), 2000, pp. 131-135